I recently attended a local conference sponsored by the LLS and a local oncology clinic involved in Phase I clinical trials. The presenting Dr. Travis stated that the clinical results showed no difference between 5 day and 7 day treatment plans. However, he stated that the 5 day plan generally produced fewer and milder side-affects.
During this same conference, Dr. Travis stated that many oncologists avoided stopping Vidaza treatment courses because patients evidenced building an immunity to the drug in between courses. (However, this was not stated with much authority.)
Ed
|